Abstract:Colony-stimulating factor 1 (CSF-1) is a homodimeric growth factor that humorally regulates the growth and differentiation of mononuclear phagocytes, and locally regulates maternal-fetal interactions during pregnancy. It exerts these actions through a transmembrane tyrosine kinase receptor, colony-stimulating factor 1 receptor (CSF-1R), the product of the c-fms proto-oncogene. Recent studies have demonstrated overexpression of CSF-1 and its receptor in breast, ovarian, and endometrial adenocarcinomas. To further investigate the possible role of CSF-1 and its receptor in the pathogenesis of endometrial adenocarcinoma, a prospective study was undertaken to study CSF-1 expression in benign and neoplastic endometrial epithelium and to compare serum CSF-1 levels in endometrial adenocarcinoma patients with healthy perimenopausal women. The mean serum levels of CSF-1 in 71 patients with endometrial cancer (4.9 +/- 1.8 microgram/liter) were significantly elevated compared with levels found in the 32 controls (3.5 +/- 1.1 microgram/liter). Within the endometrial adenocarcinoma group, circulating CSF-1 levels were significantly elevated in patients with large tumor volume, high grade, myometrial invasion, residual disease, and circulating CA-125 levels. High serum levels of serum CSF-1 were associated with elevated serum CA19-9 and CA-125 levels. Immunohistochemistry results revealed in tumor epithelium intense staining for CSF-1R (27 of 54 cases, 50%) and elevated staining for CSF-1 (41 of 54 cases, 75.9%), with intense staining of CSF-1 in 16 of 54 cases (29.6%). Staining was significantly greater in intensity and number of cells involved in malignant compared with benign epithelium for CSF-1R and CSF-1 (P = 0.05 and <0.0001, respectively). A positive correlation between amount and intensity of CSF-1 and CSF-1R staining in endometrial adenocarcinoma tissue was also demonstrated (P = 0.007). CSF-1 and CSF-1R mRNA was also detected in the tumor samples, confirming the expression of the protein in these tissues. Reverse transcription-PCR demonstrated the presence of mRNA for both the transmembrane and secreted forms of CSF-1 in all tumors analyzed. These results therefore support the hypotheses that CSF-1 and CSF-1R are overexpressed in endometrial adenocarcinoma, that levels of expression significantly correlate with clinicopathological risk factors for poor outcome, and that CSF-1 in association with its receptor via autocrine, juxtacrine, and/or paracrine interactions has a causal role in endometrial adenocarcinoma development and proliferation.

Peroxynitrite causes aspartate release from dissociated rat cerebellar granule neurones.

Expression of focal adhesion kinase in patients with endometrial cancer: a clinicopathologic study

Focal adhesion kinase overexpression in endometrial neoplasia

Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma

Elevated Expressions of SHP2 and GAB2 Correlated with VEGF in Eutopic and Ectopic Endometrium of Women with Ovarian Endometriosis.

Focal Adhesion Kinase Expression in Ovarian Endometriosis

Expression and significance of LC3 and cathepsin D in human endometrioid adenocarcinoma.

Alteration of Focal Adhesion Kinase Expression in Eutopic Endometrium of Women with Endometriosis

Prognostic and clinical significance of focal adhesion kinase expression in breast cancer: A systematic review and meta-analysis

Prognostic Significance of Vascular Endothelial Growth Factor and Its Receptors in Endometrial Carcinoma

Expression and Significance of Focal Adhesion Kinase in Ovarian Cancer

Clinical and Expression Significance of AKT1 by Co-expression Network Analysis in Endometrial Cancer.

Prognostic Value Of Focal Adhesion Kinase (Fak) In Human Solid Carcinomas: A Meta-Analysis

Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients

The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma

Establishing and Validating an Innovative Focal Adhesion-Linked Gene Signature for Enhanced Prognostic Assessment in Endometrial Cancer

Expressions of Insulin-Like Growth Factor Receptors and Estrogen Receptor Subtypes in Endometrioid Adenocarcinoma and Their Clinicopathologic Significance

Focal Adhesion Kinase Overexpression and Its Impact on Human Osteosarcoma.

Clinical significance of expression and phosphorylation of FAK in human osteosarcoma

Expression of Focal Adhesion Kinase in Carcinomas and its Clinic Signification

Epithelial Membrane Protein-2 Promotes Endometrial Tumor Formation through Activation of FAK and Src